StockData
Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc. (ARCT) stock

ARCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3010% below fair value
$7.97−0.34 (-4.09%)

Close on Nov 17, 2026Market cap $226.53MP/E –Yield –

Arcturus Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Arcturus Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.7× to 4.0×, with a median of 2.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×+0.8
2025Dec 31, 20250.7×−1.0
2024Dec 31, 20241.8×−1.3
2023Dec 29, 20233.0×−0.1
2022Dec 30, 20223.1×−0.7
2021Dec 31, 20213.8×−0.3
2020Dec 31, 20204.1×−0.5
2019Dec 31, 20194.6×–

More Arcturus Therapeutics figures

See a number that looks wrong?